MX9202936A - Compuesto de pirazinoxido de nf-1616-904 y composicion farmaceutica que lo contiene. - Google Patents

Compuesto de pirazinoxido de nf-1616-904 y composicion farmaceutica que lo contiene.

Info

Publication number
MX9202936A
MX9202936A MX9202936A MX9202936A MX9202936A MX 9202936 A MX9202936 A MX 9202936A MX 9202936 A MX9202936 A MX 9202936A MX 9202936 A MX9202936 A MX 9202936A MX 9202936 A MX9202936 A MX 9202936A
Authority
MX
Mexico
Prior art keywords
pyrazinoxide
compound
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
MX9202936A
Other languages
English (en)
Inventor
Yoshimasa Nakano
Michiharu Sugawara
Setsuyoshi Uetsuki
Taketoshi Izawa
Tomoyuki Kawaguti
Akira Wada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MX9202936A publication Critical patent/MX9202936A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9202936A 1987-08-11 1992-06-17 Compuesto de pirazinoxido de nf-1616-904 y composicion farmaceutica que lo contiene. MX9202936A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20153787 1987-08-11

Publications (1)

Publication Number Publication Date
MX9202936A true MX9202936A (es) 1992-06-30

Family

ID=16442692

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202936A MX9202936A (es) 1987-08-11 1992-06-17 Compuesto de pirazinoxido de nf-1616-904 y composicion farmaceutica que lo contiene.

Country Status (9)

Country Link
US (1) US5021419A (es)
EP (1) EP0303250B1 (es)
JP (1) JPH01131177A (es)
KR (1) KR960005150B1 (es)
CN (1) CN1028655C (es)
DE (1) DE3880231T2 (es)
DK (1) DK170617B1 (es)
ES (1) ES2054748T3 (es)
MX (1) MX9202936A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029231T2 (de) 1989-02-10 1997-03-20 Otsuka Pharma Co Ltd Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
CN1038586C (zh) * 1991-05-01 1998-06-03 大制药株式会社 吡嗪衍生物的制备方法
SE529897C2 (sv) 2006-03-27 2007-12-27 Rottneros Ab Formpressat tråg

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound

Also Published As

Publication number Publication date
DE3880231D1 (de) 1993-05-19
KR890003734A (ko) 1989-04-17
JPH01131177A (ja) 1989-05-24
KR960005150B1 (ko) 1996-04-22
DK446388A (da) 1989-02-12
JPH0557273B2 (es) 1993-08-23
EP0303250B1 (en) 1993-04-14
EP0303250A3 (en) 1990-07-11
ES2054748T3 (es) 1994-08-16
DE3880231T2 (de) 1993-10-07
CN1032031A (zh) 1989-03-29
DK446388D0 (da) 1988-08-10
US5021419A (en) 1991-06-04
DK170617B1 (da) 1995-11-13
EP0303250A2 (en) 1989-02-15
CN1028655C (zh) 1995-05-31

Similar Documents

Publication Publication Date Title
MX9202851A (es) Derivados de fosfato de los glucosidos de 4-desmetilepipodofilotoxina y composicion farmaceutica que los contiene.
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
MX9203040A (es) Derivados de quinona y composicion farmaceutica que los contiene.
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
FI101276B1 (fi) Pakkauskäyttöön tarkoitettu koostumus ja siitä valmistettu seinämä
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
MX9202910A (es) Nuevos derivados de dihidropiridina y composicion farmaceutica que los contiene.
MX9203108A (es) Compuestos de di-t-butilfenol y composiciones que los contienen.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3578422D1 (de) 3-substituierte carbacephem-verbindung und sie enthaltende pharmazeutische zusammensetzung.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
MX9203628A (es) Compuestos florados de benciltriazol y composiciones farmaceuticas que los contienen.
MX9203639A (es) 3-fenoxi-1-azetidincarboxamidas y composiciones farmaceuticas que las contienen.
FR2598617B1 (fr) Composition pharmaceutique
MX9202936A (es) Compuesto de pirazinoxido de nf-1616-904 y composicion farmaceutica que lo contiene.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
MX9203632A (es) Derivados de cicloalquiltiazol y composiciones farmaceuticas que los contienen.
TR23367A (tr) Diflorohalometoksifenil tuerevi ve adi gecen tuerevi etkili terkip maddesi olarak iceren mitisid
DE3577656D1 (de) Pharmazeutische zusammensetzungen von ceftazidim.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.